TY - JOUR
T1 - Short-term physical training in bronchial asthma
AU - Bundgaard, Allan
AU - Ingemann-Hansen, Thorsten
AU - Halkjaer-Kristensen, Jens
AU - Schmidt, Anders
AU - Bloch, Inge
AU - Kragh Andersen, Per
N1 - Funding Information:
This study was supported by the Danish Sports Research Council.
PY - 1983
Y1 - 1983
N2 - The effect of two types of physical training on patients with perennial asthma were compared in a blind, controlled, randomized study. Eleven of 27 adults with asthma performed a physical training programme which did not change their oxygen consumption (control group). The remaining 16 asthmatics performed a physical training programme which improved their maximal oxygen consumption (training group). Both of the training programmes were performed for 1 hour, twice a week during a period of 2 months. No complications were reported during the performance of the training programmes. The doses of all medicines apart from β2-agonist aerosol were unchanged during the training period. The patients inhaled β2-agonist aerosol if their peak expiratory flow (PEF) was less than 60% of their maximal PEF. The training group decreased their use of aerosol from an average of 4.94 puffs per day to 3.41 puffs per day (P < 0.05). The control group did not change their use of β2-agonist aerosol significantly. It is concluded that physical exercise which improves the maximal oxygen consumption decreases the use of β2-agonist spray and that heavy exercise is well tolerated by asthmatics.
AB - The effect of two types of physical training on patients with perennial asthma were compared in a blind, controlled, randomized study. Eleven of 27 adults with asthma performed a physical training programme which did not change their oxygen consumption (control group). The remaining 16 asthmatics performed a physical training programme which improved their maximal oxygen consumption (training group). Both of the training programmes were performed for 1 hour, twice a week during a period of 2 months. No complications were reported during the performance of the training programmes. The doses of all medicines apart from β2-agonist aerosol were unchanged during the training period. The patients inhaled β2-agonist aerosol if their peak expiratory flow (PEF) was less than 60% of their maximal PEF. The training group decreased their use of aerosol from an average of 4.94 puffs per day to 3.41 puffs per day (P < 0.05). The control group did not change their use of β2-agonist aerosol significantly. It is concluded that physical exercise which improves the maximal oxygen consumption decreases the use of β2-agonist spray and that heavy exercise is well tolerated by asthmatics.
UR - http://www.scopus.com/inward/record.url?scp=0020511614&partnerID=8YFLogxK
U2 - 10.1016/0007-0971(83)90020-7
DO - 10.1016/0007-0971(83)90020-7
M3 - Journal article
C2 - 6135442
AN - SCOPUS:0020511614
SN - 0007-0971
VL - 77
SP - 147
EP - 152
JO - British Journal of Diseases of the Chest
JF - British Journal of Diseases of the Chest
IS - C
ER -